Abstract:Objective To explore the clinical outcome of percutaneous microwave/radiofrequency ablation liver partition and portal vein embolization for planned hepatectomy (PAPEP) for the treatment of hepatocelullar carcinoma (HCC) with insufficient future liver remnant (FLR).Methods The retrospective descriptive research method was taken.The clinical data of 2 patients of giant primary HCC (FLR complicated with cirrhosis) who were admitted to the Zhejiang Province People's Hospital from November 2015 to January 2016 were collected.Treatment plan:ultrasound-guided percutaneous microwave ablation (PMA) or percutaneous radio-frequency ablation (PRA) was performed on patients under intravenous anesthesia,at the same time portal vein embolization (PVE) was conducted.FLR was measured by rescan of computed tomography (CT) at 7-9 days postoperatively,according to FLR hyperplasia and general situation of the patient,right trisegmentectomy and expanded right hemihepatectomy were implemented respectively.Observation indicatiors indicators included (1)standard liver volume (SLV) and FLR before PRA/PVE treatment,(2) liver function,body temperature,FLR and time of FLR hyperplasia after PRA/PVE treatment,(3)liver function,body temperature,complications,FLR and duration of hospital stay after hepatectomy.Follow-up using outpatient examination and telephone interview was performed to detect carcinoma recurrence and other follow-up contents up to March 2016.Results (1) Before PRA + PVE,SLVs of 2 patients were 1 103 mL and 1 132mL,FLRs of 2 patients were respectively 417 mL and 297 mL which occupied the SLV at the percentage of 37.8％ and 26.2％ respectively.(2) After PRA + PVE treatment,there were no changes in liver function and fever.After PRA + PVE treatment,FLR of 2 patients increased to 652 mLand 522 mL,respectively,which occupied the SLV at the percentage of 59.1％ and 46.1％ respectively,with increased rates of 56.4％ and 75.6％ and time of FLR hyperplasia of 10 days and 17 days.The two patients received successful hepatectomy,without intraoperative red blood cell infusion.(3) At postoperative day 3,albumin (Alb),alanine transaminase (ALT),aspartate transaminase (AST) and total bilirubin (TBil) of liver function were 28.0 g/L,63 U/L,39 U/L and 19.0 μmol/L in patient 1 with a temperature of 38 degree,and 24.3 g/L,78 U/L,11 U/L and 38.1 μmol/L in patient 2 with a normal temperature.Liver function of 2 patients was improved after conservative treatment.No severe complications were occurred.Rescan of CT showed the FLR of patients continued increasing.The duration of hospital stay of 2 patients was 10 days and 14 days,respectively.Conclusion PAPEP for HCC with insufficient FLR is safe and effective.

Surgical treatment of liver cancer with insufficient future liver remnant: controversy and consensus

Efficacy of conversion therapy on future liver remnant hypertrophy for initially unresectable colorectal liver metastases: a review of current status and perspectives

Perioperative Outcomes Comparing Laparoscopic with Open Repeat Liver Resection for Post-Hepatectomy Recurrent Liver Cancer: A Systematic Review and Meta-Analysis

[Ten-Year Retrospect of ALPPS in the Treatment of Hepatocellular Carcinoma:An Eternal Concept with Cautious Technologic Choice].

The Paradigm of Tumor Shrinkage and Rapid Liver Remnant Hypertrophy for Conversion of Initially Unresectable Colorectal Liver Metastasis: a Case Report and Literature Review

[Percutaneous Microwave/Radiofrequency Ablation Liver Partition and Portal Vein Embolization for Planned Hepatectomy for Colorectal Liver Metastases with Insufficient Future Liver Remnant].

Downstaging treatment for patients with hepatocelluar carcinoma before transplantation

Completely Laparoscopic Alpps Using Round-The-Liver Ligation To Replace Parenchymal Transection For A Patient With Multiple Right Liver Cancers Complicated With Liver Cirrhosis (Vol 24, Pg 883, 2014)

Advances of associating liver partition and portal vein ligation for staged hepatectomy in the treatment of primarilly unresectable liver cancer

Treatment of unresectable primary liver cancer: With reference to cytoreduction and sequential resection

New Challenge of Liver Surgery: Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy

Cytoreduction and Sequential Resection - A Hope for Unresectable Primary Liver-Cancer

Advances in the surgical treatment of liver cancer.

Hepatocellular Carcinoma: The Role of Surgery in Liver Cirrhosis

Comprehensive Review of Future Liver Remnant (FLR) Assessment and Hypertrophy Techniques Before Major Hepatectomy: How to Assess and Manage the FLR

Comparison of Portal Vein Embolization, Portal Vein Ligation, Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy in Cases with a Small Future Liver Remnant: a Network Meta-Analysis

Dealing with an insufficient future liver remnant: Portal vein embolization and two‐stage hepatectomy

Surgical Treatment for Recurrent Hepatocellular Carcinoma: Current Status and Challenges

Totally Laparoscopic Radiofrequency-Assisted Liver Partition with Portal Vein Ligation for Hepatocellular Carcinoma in Cirrhotic Liver

Clinical evaluation of modified ALPPS procedures based on risk-reduced strategy for staged hepatectomy

Comparison of percutaneous microwave/radiofrequency ablation liver partition and portal vein embolization versus transarterial chemoembolization and portal vein embolization for planned hepatectomy with insufficient future liver remnant